| CRISPR Medicine | This is an overview of our interviews
Scientists used lipid nanoparticles to deliver CRISPR-Cas9 targeting Hao1 for the treatment of primary hyperoxaluria type 1. Proof-of-concept studies...
Boston- and Germany-based biotech startup AIRNA is pioneering a new approach to genetic medicine by harnessing the body's natural RNA-editing...
CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of CRISPRMED24 attendees have to say about the conference in this...
In a recent CMN Live session, we spoke with Eligo Bioscience CEO Xavier Duportet about the human microbiome, its role in health and disease, and how...
Scientists have developed a method that allows for simultaneous activation, repression, and knockout of genes within a single cell. By leveraging...
Scientists developed a novel circular single-stranded DNA technology that enables highly efficient gene integration in various cell types, achieving...
Researchers at ETH Zürich have introduced a combined base and prime editing approach to explore the mutational landscape of the epithelial growth...
Researchers in Japan have used phagemids for the delivery of CRISPR components to bacteriophage, selectively killing multi-drug resistant bacteria in...
